Pertento Partners
ANAB icon

Pertento Partners’s AnaptysBio ANAB Stock Holding History

Pertento Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.4M Buy
+545,003
New +$30.8M 1.31% 19

Other funds holding ANAB

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Pertento Partners's ANAB Position: Q3 2026 in Review

Pertento Partners opened a new position in AnaptysBio (ANAB) in Q3 2026: 545,003 shares worth $27.4M. The stake represents 1.31% of the portfolio and ranks #19 among its holdings.

147 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Pertento Partners held 545,003 shares of AnaptysBio worth $27.4M as of Q3 2026.
  • AnaptysBio was a new Pertento Partners position in Q3 2026.
  • AnaptysBio made up 1.31% of Pertento Partners's portfolio in Q3 2026, its #19 holding.
  • 147 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Pertento Partners's 13F filing for Q3 2026, filed 13 Nov 2026.